Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus conventional-dose tranexamic acid in total knee arthroplasty
ChiCTR2200064365Phase 4Not yet recruiting
- Sponsor
- Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in osteoarthritis (OA) (2 arms), sponsored by Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Primary endpoint: Blood loss. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200064365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064365.